Action Center


Welcome to Consumer Action’s Take Action Center. Consumer Action offers e-advocacy tools to help you make your voice and opinions heard. The free service allows you to play active role in the political process by finding contact information for your federal and state elected officials, writing to Congress, sending letters to the editor, responding to key legislation and more. If you like our Take Action Center, consider supporting our work.



Actions by Category


Consumer Issues

Includes unfair and deceptive practices, scams and frauds, consumer rights, transparency and consumer protection.

Oppose

California Legislation

Oppose AB 1366: VOIP phone users deserve basic protections

Sponsor: Lorena Gonzalez on 2019-2-22

More Info

AB 1366 seekd to extend a loophole allowing IP-enabled services like VOIP from state regulation. All voice providers that offer the public the vital link to 9-1-1 must once again be required to provide reliable service and consumer protections, and this bill should be opposed.

Support

National Action

End annoying robocall harassment!

Date: Thu, April 04, 2019

Take Action

The Telephone Robocall Abuse Criminal Enforcement and Deterrence (TRACED) Act (S.151) would help stop annoying scam robocalls before they reach you, and make it easier to find and prosecute the scammers.

Support

National Legislation

S.151: TRACED Act

Sponsor: John Thune [R-SD] on 2019-01-16
https://consumeraction.salsalabs.org/stop-annoying-robocalls

Write Congress

26 billion robocalls were placed last year. This bipartisan bill would help stop annoying scam robocalls before they reach you, and make it easier to find and prosecute the scammers.

Support

National Legislation

H.R. 1516: To amend the Internal Revenue Code of 1986 to impose a tax on certain trading transactions.

Sponsor: Peter A. DeFazio [D-OR] on 2019-03-05
https://www.govtrack.us/congress/bills/116/hr1516

More Info

The House bill aims to create a new progressive tax on financial transactions that would generate billions in revenue, while addressing economic inequality and reducing high risk and volatility in the market.

Support

National Legislation

S. 647: Wall Street Tax Act of 2019

Sponsor: Brian Schatz [D-HI] on 2019-03-05
https://www.govtrack.us/congress/bills/116/s647

Learn More

The Senate bill would introduce a new progressive tax on financial transactions that would generate billions in revenue, while addressing economic inequality and reducing high risk and volatility in the market.

Support

National Legislation

S. 630: Arbitration Fairness for Consumers Act

Sponsor: Sherrod Brown [D-OH] on 2019-02-28
https://www.govtrack.us/congress/bills/116/s630

More Info

The bill aims to end the use of forced arbitration in student loans, credit card agreements, and employment contracts gives working Americans a fighting chance in court against powerful special interests.

Support

National Legislation

S. 583: DATA Privacy Act

Sponsor: Catherine Cortez Masto [D-NV] on 2019-02-27
https://www.govtrack.us/congress/bills/116/s583

Learn More

The DATA Privacy Act strengthens data privacy protections for American consumers while also ensuring corporations are focusing on implementing new data security standards and essential privacy protections. 

Support

National Legislation

H.R. 1046: Medicare Negotiation and Competitive Licensing Act of 2019

Sponsor: Lloyd Doggett [D-TX] on 2019-02-07
https://www.govtrack.us/congress/bills/116/hr1046

Learn More

The House bill would authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices and, if drug companies refuse to negotiate in good faith, it would enable the Secretary to issue a competitive license to another company to produce the medication as a generic.

Support

National Legislation

S. 377: Medicare Negotiation and Competitive Licensing Act of 2019

Sponsor: Sherrod Brown [D-OH] on 2019-02-07
https://www.govtrack.us/congress/bills/116/s377

More Info

The bill would authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices and, if drug companies refuse to negotiate in good faith, it would enable the Secretary to issue a competitive license to another company to produce the medication as a generic.